CAPR

Capricor Therapeutics, Inc.

Healthcare›Biotechnology|NASDAQ Global Select|US

Price

$32.11

Market Cap

$1.47B

Beta

0.48

P/E

0.0

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)-100.00%

EPS Growth (YoY)-88.33%

Revenue CAGR 3Y+0.00%

P/E Ratio0.0

PEG Ratio—

FCF Yield-5.55%

Debt / Equity0.07

Interest Coverage-35.5x

No credit card required

Already have an account? Sign in to view the full analysis for CAPR.